Patent · US Active

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors

US11535618B2 · kind B2 · utility

2Cited by

19References

21Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

Alex J. Buckmelter · Acton, US
Justin Andrew Caravella · Cambridge, US
Hongbin Li · Newtown, US
Matthew W. Martin · Arlington, US
Steven Mischke · Waltham, US
David Richard · Monroe, US
Angela V. West · Watertown, US

Key dates

Filing date	Oct 4, 2019
Grant date	Dec 27, 2022
Priority date	—
Expiry date	Oct 4, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The disclosure relates to USP30 Inhibitor Compounds I, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same. (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.